1. Home
  2. FRT vs RDY Comparison

FRT vs RDY Comparison

Compare FRT & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

N/A

Current Price

$113.81

Market Cap

10.1B

Sector

Real Estate

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$11.60

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRT
RDY
Founded
1962
1984
Country
United States
India
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
9.9B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
FRT
RDY
Price
$113.81
$11.60
Analyst Decision
Buy
Strong Buy
Analyst Count
13
1
Target Price
$112.08
$16.90
AVG Volume (30 Days)
591.7K
2.2M
Earning Date
05-01-2026
05-12-2026
Dividend Yield
4.09%
0.52%
EPS Growth
36.84
N/A
EPS
1.81
N/A
Revenue
$1,278,975,000.00
N/A
Revenue This Year
$6.10
$7.72
Revenue Next Year
$4.64
$3.50
P/E Ratio
$62.94
$18.67
Revenue Growth
6.36
N/A
52 Week Low
$90.03
$11.36
52 Week High
$128.21
$15.67

Technical Indicators

Market Signals
Indicator
FRT
RDY
Relative Strength Index (RSI) 30.58 31.42
Support Level $112.67 $11.36
Resistance Level $119.41 $13.90
Average True Range (ATR) 1.49 0.17
MACD -0.14 -0.03
Stochastic Oscillator 9.23 4.88

Price Performance

Historical Comparison
FRT
RDY

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 103 properties, which includes 28.8 million square feet of retail space and 2,500 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: